Teva Pharmaceutical Industries (NYSE:TEVA)

Major Pharma Short Interest Takes a Plunge

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

With the holiday shopping season looking strong and tax reform coming to pass as last year wound to a close, how were short sellers positioning themselves for the coming year? ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AK Steel, Carnival, FedEx, PayPal, Sunoco, Teva, Under Armour, Wells Fargo and More

Stocks were mixed on Monday, following four consecutive days of gains, and Tuesday was indicated to have a strong open. The markets are effectively at all-time highs, and the raging ...
Read Full Story »

Why Alder Biopharma Is Winning Big on Monday

Alder Biopharmaceuticals Inc. (NASDAQ: ALDR) saw its shares make a solid gain on Monday amid a blizzard of updates from the company. Overall, the firm met its primary endpoint in ...
Read Full Story »

20 More Biopharma Catalysts Coming in 2018

Over the course of 2017, biopharmaceutical companies more or less kept pace with the markets, ending up with a return just a little higher than the S&P 500. But going in ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva, Tyson, Walgreens and More

Stocks have risen in each of the first three days of 2018, hitting new high after new high. The Dow Jones Industrial Average rose over 25% in 2017 and is ...
Read Full Story »

More and More Short Sellers Raising the Stakes in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Is Teva Finally Back on Track?

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) saw its shares make a small gain on Wednesday after the firm announced the exclusive launch of a generic version of Reyataz (atazanavir) capsules ...
Read Full Story »

FDA Accepts Teva Pharma’s BLA for Migraine Drug

After running through what was a volatile past week, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) seems to be settling down — at least a little. The Israeli pharma giant kicked ...
Read Full Story »

Teva Pharmaceuticals: Happy Holidays, You’re Fired

Another company has decided that the best time to fire a large number of people is just before the holidays. While there are some concrete reasons to do so, the ...
Read Full Story »

6 Most Important Things in Business Today

Henry Blodget's Business Insider, one of the greatest digital media successes, will change its name to Insider, Inc., a sign of its growing influence outside business and finance. The FCC ...
Read Full Story »

Investors Can’t Seem to Make Up Their Minds on Teva’s Restructuring

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares turned south on Wednesday after the company said that it would be announcing its restructuring plan on Thursday. Previously, investors had responded positively ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Will Consumers Trust Generic Viagra?

If there is one drug from pharmaceutical giants that may have changed the world in lifestyle, Viagra might be the first one that comes to mind. It has helped millions ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Best Buy, Equifax, Gilead, MongoDB, NVIDIA, Rio Tinto, Teva, UPS and More

Stocks were indicated to open lower on Monday, with all major U.S. equity indexes down about 0.3% on average. What investors still need to consider is that the stock indexes ...
Read Full Story »